Zhengye Biotechnology Holding Limited Revenue from Contract with Customer, Excluding Assessed Tax
Zhengye Biotechnology Holding Limited (ZYBT) reported Revenue from Contract with Customer, Excluding Assessed Tax of CNY 186.36 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-07-03.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-07-03
CNY
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|
| 2024-12-31 | 186.36M CNY 20-F · filed 2025-07-03 |
| 2023-12-31 | 211.65M CNY 20-F · filed 2025-07-03 |
| 2022-12-31 | 260.27M CNY 20-F · filed 2025-07-03 |
USD
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|
| 2024-12-31 | $25.53M 20-F · filed 2025-07-03 |